Af­ter three-decade jour­ney, Geron sees new life in PhI­II da­ta on MDS drug, plots path to ap­proval

Geron, found­ed in 1990 as an an­ti-ag­ing com­pa­ny, has al­most com­plet­ed its meta­mor­pho­sis.

Wednes­day morn­ing, the Bay Area biotech un­veiled that its drug ime­tel­stat suc­ceed­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER